Deferoxamine
Showing 1 - 25 of 87
Diabetic Foot Ulcer Trial (Deferoxamine, Placebo)
Not yet recruiting
- Diabetic Foot Ulcer
- Deferoxamine
- Placebo
- (no location specified)
May 25, 2022
Ischemic Stroke, Acute Trial in Spain (Deferoxamine)
Completed
- Ischemic Stroke, Acute
- Deferoxamine
-
Badalona, Barcelona, Spain
- +3 more
Aug 4, 2022
Triple Negative Breast Cancer Trial in Guangzhou (Deferoxamine Plus Chemotherapy)
Recruiting
- Triple Negative Breast Cancer
- Deferoxamine Plus Chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 28, 2022
Aneurysmal Subarachnoid Hemorrhage Trial in Ann Arbor, Beijing (Deferoxamine, Placebo)
Recruiting
- Aneurysmal Subarachnoid Hemorrhage
- Deferoxamine
- Placebo
-
Ann Arbor, Michigan
- +1 more
Mar 28, 2022
Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))
Recruiting
- Leptomeningeal Metastases
- Deferoxamine (DFO)
-
Basking Ridge, New Jersey
- +6 more
Jun 27, 2022
Acute Kidney Injury Trial in Boston (Deferoxamine, Normal saline)
Recruiting
- Acute Kidney Injury
- Deferoxamine
- Normal saline
-
Boston, Massachusetts
- +2 more
Feb 3, 2022
Chronic Cutaneous Ulcer, Sickle Cell Disease Trial in United States (Deferoxamine Product, Placebo)
Withdrawn
- Chronic Cutaneous Ulcer
- Sickle Cell Disease
- Deferoxamine Product
- Placebo
-
Birmingham, Alabama
- +3 more
Nov 21, 2021
Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))
Completed
- Thalassemia
- Iron Overload
- Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
-
Oakland, CaliforniaCHRCO
Jul 20, 2021
Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in
Not yet recruiting
- Brain Ischemia
- Serum Iron
- +7 more
-
Aswan, EgyptAswan University Hospital
Mar 7, 2023
Cardiac Iron Overload Trial in Worldwide (Deferasirox and Deferoxamine)
Completed
- Cardiac Iron Overload
- Deferasirox and Deferoxamine
-
Toronto, Ontario, Canada
- +14 more
Jul 23, 2021
Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant
Recruiting
- Acute Myocardial Infarction
- +4 more
- Antioxidant formula
- Dextrose 5% in water
-
Santiago de Chile, ChileUniversity of Chile
Jan 17, 2022
COVID19, Intensive Care Unit Trial in Ariana (Tocilizumab Injection, Deferoxamine)
Unknown status
- COVID19
- Intensive Care Unit
- Tocilizumab Injection
- Deferoxamine
-
Ariana, TunisiaEshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Aria
Aug 26, 2020
Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)
Completed
- Iron Overload
- +2 more
- Omega 3
- +5 more
-
Banī Suwayf, Egypt
- +3 more
Jan 25, 2021
Deferoxamine for the Treatment of Hemochromatosis
Completed
- Diabetes Mellitus
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
COVID-19 Trial in Kermanshah (Deferoxamine)
Unknown status
- COVID-19
- Deferoxamine
-
Kermanshah, Iran, Islamic Republic ofRegenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020
Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))
Terminated
- Transfusion-dependent β-thalassemia Patients
- Cardiac Iron Overload
- Deferasirox
- Deferoxamine (DFO)
-
Athens, GR, Greece
- +3 more
Oct 21, 2019
Bone Denisty Change in Children With Beta Thalassemia Major
Not yet recruiting
- Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
- Dexa scan
- (no location specified)
Sep 29, 2023
Hepatocellular Carcinoma Non-resectable Trial in Jinan (Conventional TACE, Deferoxamine and conventional TACE)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Conventional TACE
- Deferoxamine and conventional TACE
-
Jinan, Shandong, China960th hospital of PLA
Feb 20, 2019
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and
Not yet recruiting
- Multiple Sclerosis
- Progressive Multifocal Leukoencephalopathy
- 89 Zr-Df-crefmirlimab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Intracerebral Hemorrhage Trial in Canada, United States (Deferoxamine, Normal saline)
Terminated
- Intracerebral Hemorrhage
- Deferoxamine
- Normal saline
-
Phoenix, Arizona
- +28 more
May 29, 2019
Intracerebral Hemorrhage Trial in Canada, United States (Deferoxamine Mesylate, Placebo (for Deferoxamine Mesylate))
Completed
- Intracerebral Hemorrhage
- Deferoxamine Mesylate
- Placebo (for Deferoxamine Mesylate)
-
Phoenix, Arizona
- +27 more
May 29, 2019
Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)
Completed
- Transfusion-dependent Hemachromatosis
- +2 more
- Deferoxamine
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 14, 2019
Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)
Not yet recruiting
- Cervical Cancer
- +13 more
- (no location specified)
Sep 28, 2022